Publication:
Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia/reperfusion injury and oxidative damage in isolated rat heart.

Simple item page
dc.contributor.authorKilic, AYSU
dc.contributor.authorUstunova, SAVAŞ
dc.contributor.authorUsta, C
dc.contributor.authorMeral, İSMAİL
dc.contributor.authorDemirci, Tansel
dc.contributor.authorGurel, Gurevin
dc.contributor.institutionauthorKILIÇ, AYSU
dc.contributor.institutionauthorÜSTÜNOVA, SAVAŞ
dc.contributor.institutionauthorMERAL, İSMAİL
dc.date.accessioned2019-10-05T23:27:04Z
dc.date.available2019-10-05T23:27:04Z
dc.date.issued2019-07-30
dc.description.sponsorshipBezmialem Vakıf Üniversitesi
dc.identifier10.4149/bll_2018_129
dc.identifier.citationKilic A., Ustunova S., Usta C., Bulut H., Meral İ., Demirci T., Gurel G., -Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia/reperfusion injury and oxidative damage in isolated rat heart.-, Canadian journal of physiology and pharmacology, 2019
dc.identifier.doi10.1139/cjpp-2019-0076
dc.identifier.pubmed31361968
dc.identifier.urihttps://hdl.handle.net/20.500.12645/10245
dc.language.isoen
dc.titleAngiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia/reperfusion injury and oxidative damage in isolated rat heart.
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameBratislavske lekarske listy
local.avesis.idffdff6d6-4dc5-4a7f-b416-4c4301b30c9b
local.indexed.atPubMed
local.publication.isinternational1
relation.isAuthorOfPublicationcac708f1-3a64-4312-b507-ad94d4212f60
relation.isAuthorOfPublicationbebec550-3712-466a-8e2d-8f90006e62f6
relation.isAuthorOfPublication58058ee9-1440-480c-9817-c6b25d7ec008
relation.isAuthorOfPublication.latestForDiscovery58058ee9-1440-480c-9817-c6b25d7ec008

Files

Collections

Yayınlar - Eserler
Tıp Fakültesi